Inotiv Inc.

NASDAQ: NOTV · Real-Time Price · USD
1.76
-0.28 (-13.73%)
At close: May 06, 2025, 3:59 PM
1.77
0.57%
After-hours: May 06, 2025, 07:53 PM EDT
-13.73%
Bid 1.77
Market Cap 59.61M
Revenue (ttm) 475.11M
Net Income (ttm) -120.69M
EPS (ttm) -4.61
PE Ratio (ttm) -0.38
Forward PE -1.73
Analyst Buy
Ask 1.79
Volume 276,038
Avg. Volume (20D) 777,993
Open 1.97
Previous Close 2.04
Day's Range 1.75 - 1.99
52-Week Range 1.15 - 6.48
Beta 4.06

About NOTV

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, r...

Sector Healthcare
IPO Date Nov 25, 1997
Employees 1,977
Stock Exchange NASDAQ
Ticker Symbol NOTV
Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for NOTV stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 127.27% from the latest price.

Stock Forecasts

Next Earnings Release

Inotiv Inc. is scheduled to release its earnings on May 7, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-28.83%
Inotic shares are trading lower after the company ... Unlock content with Pro Subscription
4 months ago
-4.48%
Inotic shares are trading lower after the company announced a public offering of common shares with a 15% over-allotment option.